Key result
Inferior mesenteric artery >4 mm linked to ~7-fold higher intervention risk in type II endoleaks.
Why the study?
Lifelong surveillance is essential after EVAR because endoleaks remain a major cause of reintervention, but the optimal management of type II endoleaks remains controversial.
Do large IMA, multiple lumbar arteries, and anticoagulation predict the need for intervention in patients with type II endoleaks after EVAR?
Cohort (n=207)
Do large IMA, multiple lumbar arteries, and anticoagulation predict the need for intervention in patients with type II endoleaks after EVAR?
Effect estimate: HR 7.18 (95% CI 1.97-26.16)
p-value: p=<0.01
An inferior mesenteric artery >4 mm, >6 lumbar arteries, and anticoagulation use are strong predictors for requiring embolization in patients with type II endoleaks after EVAR.
Large IMA associated with type II endoleak intervention after EVAR; leaves open benefit of prophylactic embolization pending RCTs.
Introduction Endovascular abdominal aortic aneurysm repair (EVAR) is the primary treatment for abdominal aortic aneurysm (AAA). Despite favorable early outcomes, lifelong surveillance is essential as endoleaks remain a major cause of reintervention. Among these, type II endoleaks (T2E) remain controversial regarding optimal management. This study aimed to identify factors associated with intervention for T2E using time-to-event analysis and predefined anatomic thresholds. Secondary objectives included comparing outcomes between T2E patients with (intT2E) and without (nointT2E) intervention. Methods A retrospective review of EVAR procedures from 2011-2024 was performed. Patients with newly diagnosed or persistent T2E were identified on completion and follow-up CT angiography. Patients were categorized as intT2E or nointT2E. Multivariable Cox regression evaluated time to first intervention, and logistic regression served as sensitivity analysis. Kaplan-Meier curves assessed freedom from intervention by inferior mesenteric artery (IMA) size. Results Among 207 EVAR patients, 78 (37.6%) developed T2E over a mean 3.4 ± 2.4 years. Nineteen (24.3%) required intervention. IntT2E patients were younger (74.9 ± 6.8 vs 78.3 ± 7.9 years, P = 0.02), had more frequent anticoagulation use (47.4% vs 20.3%, P = 0.02), larger IMAs (4.2 ± 0.6 vs 3.3 ± 0.7 mm, P < 0.01), and more lumbar arteries (6.0 ± 1.2 vs 5.0 ± 1.3, P = 0.02). IMAs >4 mm occurred in 68.4% of intT2E vs 8.5% of nointT2E ( P < 0.01). Mean sac growth was greater in intT2E (9.7 ± 5.3 mm vs −1.9 ± 6.5 mm, P < 0.01). Thirty-day complications following the index EVAR procedure, mid-term reinterventions, and overall mortality were similar between groups. Post-embolization, T2E resolved in 36.9%, with sac regression in 63.1%. Among embolized patients, 26.3% required a second embolization and one patient required 3 attempts without achieving resolution. IMA >4 mm independently predicted intervention (HR 7.18, 95% CI 1.97-26.16, P < 0.01). Logistic regression confirmed IMA >4 mm (OR 23.4, 95% CI 6.17-88.6, P < 0.01), >6 lumbar arteries (OR 4.2, 95% CI 1.10-15.98, P = 0.02), and anticoagulation (OR 3.4, 95% CI 1.17-10.6, P = 0.02) as predictors. Conclusions Approximately one-quarter of T2E patients required embolization. IMA >4 mm was the strongest predictor of intervention, while anticoagulation and increased lumbar artery number also increased risk. Management should prioritize risk-stratified surveillance and selective intervention.
No takes yet. Share an insight, caveat, or question.
Vernon et al. (2026) conducted a cohort in Type II endoleaks after endovascular abdominal aortic aneurysm repair (n=207). Inferior mesenteric artery (IMA) >4 mm vs. IMA ≤4 mm was evaluated on Time to first intervention for type II endoleak (HR 7.18, 95% CI 1.97-26.16, p=<0.01). An inferior mesenteric artery >4 mm independently predicted the need for intervention in patients with type II endoleaks (HR 7.18; 95% CI 1.97-26.16; P<0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: